CMS broadens defibrillator query
This article was originally published in The Gray Sheet
Executive Summary
Agency is gathering further evidence on the necessity of threshold-testing at the time of implantation. The second round of comments will inform CMS' review of appropriate ICD use, the agency notes June 23. CMS also is seeking evidence on the risks and benefits of adding anti-tachycardia pacing to ICD functions. Considerations include the risk of an additional lead and whether justification exists for developing a patient registry "to collect information to better identify predictors of ICD firing for ventricular fibrillation as a proxy for sudden cardiac death." Commenters should base answers on published literature rather than clinical practice...
You may also be interested in...
Defibrillator comment period
July 23 is the deadline for submitting second-round comments on expanding ICD national coverage, CMS clarifies. The agency is interested in evidence regarding the necessity of threshold testing at the time of ICD implantation (1"The Gray Sheet" June 28, 2004, In Brief)...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.